The importance of MLH1 in CRC and its propensity for hypermethylation have been known for some time3, and there is a substantial body of literature about the use of MLH1 methylation and/or MSI as a biomarker in the classification of CRC. This evidence concerns the gene MLH1 and colorectal carcinoma.